Todd Harris - 21 Mar 2023 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Executive Officer, Director
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
21 Mar 2023
Net transactions value
-$264,495
Form type
4
Filing time
23 Mar 2023, 19:49:09 UTC
Previous filing
17 Mar 2023
Next filing
28 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Options Exercise $27,884 +12,393 +0.73% $2.25* 1,713,669 21 Mar 2023 Direct
transaction TYRA Common Stock Sale $198,288 -12,393 -0.72% $16.00 1,701,276 21 Mar 2023 Direct F1
transaction TYRA Common Stock Options Exercise $9,097 +4,043 +0.24% $2.25* 1,705,319 22 Mar 2023 Direct
transaction TYRA Common Stock Sale $64,688 -4,043 -0.24% $16.00 1,701,276 22 Mar 2023 Direct F1
transaction TYRA Common Stock Options Exercise $6,300 +2,800 +0.16% $2.25* 1,704,076 23 Mar 2023 Direct
transaction TYRA Common Stock Sale $44,800 -2,800 -0.16% $16.00 1,701,276 23 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -12,393 -2.9% $0.000000 416,619 21 Mar 2023 Common Stock 12,393 $2.25 Direct F2
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -4,043 -0.97% $0.000000 412,576 22 Mar 2023 Common Stock 4,043 $2.25 Direct F2
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -2,800 -0.68% $0.000000 409,776 23 Mar 2023 Common Stock 2,800 $2.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
F2 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.